2269.HK vs. SYNGENE.NS

Last updated Apr 3, 2026

Compare and contrast key facts about WuXi Biologics (2269.HK) and Syngene International Limited (SYNGENE.NS).

Performance

2269.HK vs. SYNGENE.NS - Performance Comparison

The chart below illustrates the hypothetical performance of a HK$10,000 investment in WuXi Biologics (2269.HK) and Syngene International Limited (SYNGENE.NS). The values are adjusted to include any dividend payments, if applicable.

2269.HK vs. SYNGENE.NS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
2269.HK WuXi Biologics	11.26%	78.64%	-40.54%	-50.54%	-35.33%	-9.26%	210.19%	96.71%	14.76%	54.69%
SYNGENE.NS Syngene International Limited	-41.31%	-27.50%	18.61%	19.36%	-14.69%	-4.48%	94.58%	11.02%	-4.81%	17.87%

Different Trading Currencies

2269.HK is traded in HKD, while SYNGENE.NS is traded in INR. To make them comparable, the SYNGENE.NS values have been converted to HKD using the latest available exchange rates.

Returns By Period

In the year-to-date period, 2269.HK achieves a 11.26% return, which is significantly higher than SYNGENE.NS's -41.31% return.

2269.HK

• 1D: 0.34%
• 1M: -5.46%
• YTD: 11.26%
• 6M: -16.87%
• 1Y: 33.26%
• 3Y*: -9.57%
• 5Y*: -19.75%
• 10Y*: —

SYNGENE.NS

• 1D: -1.30%
• 1M: -6.02%
• YTD: -41.31%
• 6M: -40.29%
• 1Y: -49.58%
• 3Y*: -15.93%
• 5Y*: -10.85%
• 10Y*: 4.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

2269.HK vs. SYNGENE.NS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

2269.HK

2269.HK Risk / Return Rank: 60
2269.HK Sharpe Ratio Rank: 62
2269.HK Sortino Ratio Rank: 57
2269.HK Omega Ratio Rank: 58
2269.HK Calmar Ratio Rank: 61
2269.HK Martin Ratio Rank: 62

SYNGENE.NS

SYNGENE.NS Risk / Return Rank: 2
SYNGENE.NS Sharpe Ratio Rank: 0
SYNGENE.NS Sortino Ratio Rank: 1
SYNGENE.NS Omega Ratio Rank: 2
SYNGENE.NS Calmar Ratio Rank: 3
SYNGENE.NS Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2269.HK vs. SYNGENE.NS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WuXi Biologics (2269.HK) and Syngene International Limited (SYNGENE.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	2269.HK	SYNGENE.NS	Difference
Sharpe ratio Return per unit of total volatility	0.63	-1.57	+2.20
Sortino ratio Return per unit of downside risk	1.12	-2.35	+3.46
Omega ratio Gain probability vs. loss probability	1.16	0.70	+0.46
Calmar ratio Return relative to maximum drawdown	0.98	-0.95	+1.93
Martin ratio Return relative to average drawdown	2.38	-2.06	+4.44
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

2269.HK vs. SYNGENE.NS - Sharpe Ratio Comparison

The current 2269.HK Sharpe Ratio is 0.63, which is higher than the SYNGENE.NS Sharpe Ratio of -1.57. The chart below compares the historical Sharpe Ratios of 2269.HK and SYNGENE.NS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	2269.HK	SYNGENE.NS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.63	-1.57	+2.20
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.30	-0.39	+0.09
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.15	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.27	0.19	+0.09

Correlation

The correlation between 2269.HK and SYNGENE.NS is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

2269.HK vs. SYNGENE.NS - Dividend Comparison

2269.HK has not paid dividends to shareholders, while SYNGENE.NS's dividend yield for the trailing twelve months is around 0.32%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
2269.HK WuXi Biologics	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SYNGENE.NS Syngene International Limited	0.32%	0.19%	0.15%	0.18%	0.17%	0.00%	0.00%	0.16%	0.18%	0.18%	0.18%

Drawdowns

2269.HK vs. SYNGENE.NS - Drawdown Comparison

The maximum 2269.HK drawdown since its inception was -92.95%, which is greater than SYNGENE.NS's maximum drawdown of -62.76%. Use the drawdown chart below to compare losses from any high point for 2269.HK and SYNGENE.NS.

Drawdown Indicators

	2269.HK	SYNGENE.NS	Difference
Max Drawdown Largest peak-to-trough decline	-92.95%	-58.78%	-34.17%
Max Drawdown (1Y) Largest decline over 1 year	-28.29%	-47.85%	+19.56%
Max Drawdown (5Y) Largest decline over 5 years	-92.95%	-58.78%	-34.17%
Max Drawdown (10Y) Largest decline over 10 years	—	-58.78%	—
Current Drawdown Current decline from peak	-75.98%	-58.66%	-17.32%
Average Drawdown Average peak-to-trough decline	-42.31%	-13.37%	-28.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.73%	21.91%	-7.18%

Volatility

2269.HK vs. SYNGENE.NS - Volatility Comparison

WuXi Biologics (2269.HK) has a higher volatility of 14.41% compared to Syngene International Limited (SYNGENE.NS) at 12.28%. This indicates that 2269.HK's price experiences larger fluctuations and is considered to be riskier than SYNGENE.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	2269.HK	SYNGENE.NS	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.41%	12.28%	+2.13%
Volatility (6M) Calculated over the trailing 6-month period	31.76%	23.04%	+8.72%
Volatility (1Y) Calculated over the trailing 1-year period	54.68%	31.77%	+22.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.79%	28.44%	+38.35%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	60.32%	30.10%	+30.22%

Financials